The Oncology Institute, Inc.
General ticker "TOI" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $164.7M (TTM average)
The Oncology Institute, Inc. follows the US Stock Market performance with the rate: 42.1%.
Estimated limits based on current volatility of 3.3%: low 2.92$, high 3.12$
Factors to consider:
- Total employees count: 750 as of 2022
- Top business risk factors: Pandemic risks, Internal control weaknesses, Rapid growth and organizational change, Market competition, Labor/talent shortage/retention
- Current price 377.7% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.14$, 0.68$]
- 2025-12-31 to 2026-12-31 estimated range: [0.20$, 0.88$]
Short-term TOI quotes
Long-term TOI plot with estimates
Financial data
| YTD | 2024-12-31 |
|---|---|
| Operating Revenue | $393.41MM |
| Operating Expenses | $453.53MM |
| Operating Income | $-60.12MM |
| Non-Operating Income | $-4.54MM |
| Interest Expense | $7.50MM |
| Income(Loss) | $-64.66MM |
| Profit(Loss)* | $-53.01MM |
| Stockholders Equity | $3.59MM |
| Assets | $172.72MM |
| Operating Cash Flow | $-26.54MM |
| Capital expenditure | $3.79MM |
| Investing Cash Flow | $46.21MM |
| Financing Cash Flow | $-3.49MM |
| Earnings Per Share** | $-0.71 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.